insights_auto
Why is CGEM up 4,72%?
Dive Deeperchevron_right
CGEM:NASDAQ
Cullinan Therapeutics Inc
US$11,31
arrow_upward
+4,72%(+0,51) 1D
US$11,51
arrow_upward
+1,77% (+0,20)bedtimeAfter hours
Closed: 6 ພ.ຈ., 16 ໂມງ 0 ນາທີ 01 ວິນາທີ GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CGEM...
Open
US$11,09
High
US$11,77
Low
US$10,69
Mkt. cap
727,85 ລ້ານ
Avg. vol.
926,44 ພັນ
Volume
755,71 ພັນ
52-wk high
US$23,19
52-wk low
US$6,73
EPS
US$-3,41
Beta
-0,03
Shares outstanding
64,36 ລ້ານ
No. of employees
109
Open
US$11,09
High
US$11,77
Low
US$10,69
Mkt. cap
727,85 ລ້ານ
Avg. vol.
926,44 ພັນ
Volume
755,71 ພັນ
52-wk high
US$23,19
52-wk low
US$6,73
EPS
US$-3,41
Beta
-0,03
Shares outstanding
64,36 ລ້ານ
No. of employees
109
News stories
From web sources and news partners
GuruFocus
·
44 ນາທີກ່ອນ
Nasdaq (NDAQ) to Launch 23-Hour Trading Model Starting December 6
Bloomberg.com
·
16 ຊົ່ວໂມງກ່ອນ
Wall Street Strategists Call Stock Rout a Fresh Reason to Buy
About Cullinan Therapeutics Inc
CEO-
Employees109
Founded2016
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websitecullinantherapeutics.com